Financial Information

KemPharm® is a clinical stage, specialty pharmaceutical company engaged in the development and discovery of proprietary prodrugs that are designed to be improved versions of widely prescribed and FDA approved products.

Financial Information

Filing date Form Description Filing Group View
S-8

Securities offered to employees pursuant to employee benefit plans

Registration Statements
View HTML
10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
SC 13G/A

An amendment to the SC 13G filing

3,4,5
View HTML
SC 13G/A

An amendment to the SC 13G filing

3,4,5
View HTML
SC 13G

A statement of beneficial ownership of common stock by certain persons

3,4,5
View HTML
SC 13G/A

An amendment to the SC 13G filing

3,4,5
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML